Neurotransmitter Abnormalities in Patients With Motor Neuron Disease
- 1 July 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 38 (7) , 415-417
- https://doi.org/10.1001/archneur.1981.00510070049006
Abstract
• In 22 patients with motor neuron disease (MND), the mean concentration of serotonin (5HT) in platelets was slightly increased, platelet monoamine oxidase (MAO) activity was significantly increased, and plasma concentrations of total and both free and bound tryptophan were significantly decreased. Though platelet MAO activity was positively correlated with concentrations of 5HT, independent causal mechanisms are probable. When patients were rated according to severity, highest values of platelet 5HT and MAO activity were found in the most severely affected group, whereas concentrations of both total and protein-bound tryptophan were most decreased. Changes in concentrations of 5HT and tryptophan may reflect compensatory changes in response to degeneration of motor neurons or to interruption of their monoaminergic innervation.This publication has 8 references indexed in Scilit:
- Norepinephrine and gamma‐aminobutyric acid in amyotrophic lateral sclerosisNeurology, 1980
- Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases.Journal of Neurology, Neurosurgery & Psychiatry, 1979
- Serotonergic facilitation of facial motoneuron excitationBrain Research, 1979
- Effects of the diet on brain neurotransmittersMetabolism, 1977
- Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over timeBiochemical Medicine, 1976
- Serotonin content of the brain stem nuclei in the ratBrain Research, 1974
- Blood platelets as a model for monoamine-containing neuronesProgress in Neurobiology, 1973
- Free Tryptophan in Plasma and Brain Tryptophan MetabolismNature, 1972